Guardant Health Inc

NASDAQ:GH 1:00:00 PM EDT

50.50

+0.32 (+0.64%)

2:14:08 PM EDT: $50.25 -0.25 (-0.50%)

Market Cap (Intraday)	6.26B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$211.21 Million
Adjusted EPS	-$0.72

See more estimates

10-Day MA	$50.20
50-Day MA	$45.50
200-Day MA	$37.81

See more pivots

Guardant Health Inc Stock, NASDAQ:GH

3100 Hanover Street, Palo Alto, California 94304

United States of America

Phone: +1.855.698.8887

Number of Employees: 2021

http://www.guardanthealth.com

Description

Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.